← Leaderboards
Sarah A Spinler
University Of Pennsylvania
$1,200,558
Attributed
$1,200,558
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,200,558 · 3
By mechanism
M01$1,200,558 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Garret A Fitzgerald$242,218,424
- Emma Meagher$1,473,964
- Francesca Catella-Lawson$1,843,768
- Emer Maria Smyth$2,881,375
- Mary F Morrison$273,406
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHuman Therapy EvaluationDrug Screening /EvaluationClinical Trial Phase IAspirinChemosensitizing AgentClinical TrialsCombination ChemotherapyDietary SupplementsDrug Administration RoutesDrug InteractionsEnalaprilFibrinolytic TherapyHigh Density LipoproteinsHyperlipidemiaHypertensionLow Density LipoproteinMetabolism Disorder ChemotherapyNutrition Related TagOral AdministrationPharmacokineticsPlatelet Aggregation InhibitorsThromboxanes
Grant awards (9)
EFFECT OF ASCORBIC ACID &ALPHA TOCOPHEROL IN HYPERLIPIDEMIA$187,536
M01 · FY2000 · RR
EFFECT OF ASCORBIC ACID &ALPHA TOCOPHEROL IN HYPERLIPIDEMIA$187,536
M01 · FY2000 · RR
ASA EFFECTS ON ANTIHYPERTENSIVE EFFICACIES OF ENALAPRIL AND LOSARTAN$187,536
M01 · FY2000 · RR
ASA EFFECTS ON ANTIHYPERTENSIVE EFFICACIES OF ENALAPRIL AND LOSARTAN$187,536
M01 · FY2000 · RR
ANTIPLATELET EFFECT AND PHARMACOKINETIC COMPARISON OF ORAL VS RECTAL ASPIRIN$187,536
M01 · FY2000 · RR
ANTIPLATELET EFFECT AND PHARMACOKINETIC COMPARISON OF ORAL VS RECTAL ASPIRIN$187,536
M01 · FY2000 · RR
EFFECT OF ASCORBIC ACID &ALPHA TOCOPHEROL IN HYPERLIPIDEMIA$25,114
M01 · FY2000 · RR
ANTIPLATELET EFFECT AND PHARMACOKINETIC COMPARISON OF ORAL VS RECTAL ASPIRIN$25,114
M01 · FY2000 · RR
ASA EFFECTS ON ANTIHYPERTENSIVE EFFICACIES OF ENALAPRIL AND LOSARTAN$25,114
M01 · FY2000 · RR